Drug Type Small molecule drug |
Synonyms GP-801 |
Target |
Mechanism SDF-1 antagonists(C-X-C motif chemokine ligand 12 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Phase 2 | US | 12 Oct 2022 | |
Heart Failure | Phase 2 | CN | 12 Oct 2022 | |
Peripheral Arterial Disease | Phase 2 | US | 12 Oct 2022 | |
Peripheral Arterial Disease | Phase 2 | CN | 12 Oct 2022 | |
Cicatrix | Phase 1 | CN | 12 Oct 2022 | |
Muscle injury | Preclinical | CN | 12 Oct 2022 | |
Urinary Incontinence | Preclinical | CN | 12 Oct 2022 |